LSD enhances suggestibility in healthy volunteers
This within-subjects, placebo-controlled study (n=10) found that the influence of suggestion is enhanced by LSD, especially in individuals with high trait 'conscientiousness', which may have implications for the use of LSD in psychotherapy.
Authors
- Bolstridge, M.
- Carhart-Harris, R. L.
- Feilding, A.
Published
Abstract
Rationale: Lysergic acid diethylamide (LSD) has a history of use as a psychotherapeutic aid in the treatment of mood disorders and addiction, and it was also explored as an enhancer of mind control.Objectives: The present study sought to test the effect of LSD on suggestibility in a modern research study.Methods: Ten healthy volunteers were administered with intravenous (i.v.) LSD (40-80 μg) in a within-subject placebo-controlled design. Suggestibility and cued mental imagery were assessed using the Creative Imagination Scale (CIS) and a mental imagery test (MIT). CIS and MIT items were split into two versions (A and B), balanced for ‘efficacy’ (i.e. A≈B) and counterbalanced across conditions (i.e. 50 % completed version ‘A’ under LSD). The MIT and CIS were issued 110 and 140 min, respectively, post-infusion, corresponding with the peak drug effects.Results: Volunteers gave significantly higher ratings for the CIS (p = 0.018), but not the MIT (p = 0.11), after LSD than placebo. The magnitude of suggestibility enhancement under LSD was positively correlated with trait conscientiousness measured at baseline (p = 0.0005).Conclusions: These results imply that the influence of suggestion is enhanced by LSD. Enhanced suggestibility under LSD may have implications for its use as an adjunct to psychotherapy, where suggestibility plays a major role. That cued imagery was unaffected by LSD implies that suggestions must be of a sufficient duration and level of detail to be enhanced by the drug. The results also imply that individuals with high trait conscientiousness are especially sensitive to the suggestibility-enhancing effects of LSD.
Research Summary of 'LSD enhances suggestibility in healthy volunteers'
Study Details
- Study Typeindividual
- Populationhumans
- Characteristicscrossoverplacebo controlledsingle blind
- Journal
- Compounds
- Topic
Cited By (105)
Papers in Blossom that reference this study
Fejer, G., Fiacchino, D., Hommel, B. et al. · Neuropsychopharmacology (2025)
Carter, A., Gardner, J., Ham, R. et al. · OSF Preprints (2025)
Doss, M. K., Kloft, L., Mallaroni, P. et al. · Journal of Psychopharmacology (2024)
Banks, M. I., Dunne, J. D., Hutson, P. R. et al. · Translational Psychiatry (2024)
Beit, C., Blevins, K., Evans, N. G. et al. · Neuroethics (2024)
Aday, J. S., Bradley, E. R., Fernandes-Osterhold, G. et al. · Psychopharmacology (2024)
Barba, T., Carhart-Harris, R. L., Erritzoe, D. et al. · Journal of Psychopharmacology (2024)
Brand, M., Gründer, G., Jungaberle, H. et al. · Lancet Psychiatry (2024)
De Filippo, R., Schmitz, D. · Neuroscience and Biobehavioral Reviews (2024)
Brauer, E., Dunlop, B. W., Grant, G. H. et al. · PLOS ONE (2024)
Show all 105 papersShow fewer
Lafrance, A., Miller, A. K., Williams, M. · Eating Disorders - The Journal of Treatment & Prevention (2023)
Buchborn, T., Kartner, L., Kettner, H. et al. · Frontiers in Neuroscience (2023)
Fried, E. I., van Elk, M. · Therapeutic Advances in Psychopharmacology (2023)
Bentancourt, I., Bramen, J., Heinzerling, K. G. et al. · Frontiers in Psychiatry (2023)
Bedi, G., Muthukumaraswamy, S., Noorani, T. N. · Psychological Medicine (2023)
Hartogsohn, I., Pronovost-Morgan, C., Ramaekers, J. G. · Journal of Psychopharmacology (2023)
Bright, S. J., Bruno, R., Sharbanee, J. M. et al. · Journal of Humanistic Psychology (2023)
Beck, A., Byrne, K., Garland, E. L. et al. · Journal of Psychedelic Studies (2023)
Gross, R., Lev-Ran, S., Rabinowitz, J. · Frontiers in Psychiatry (2023)
Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. et al. · Neuropharmacology (2022)
Devenot, N., Garcia-Romeu, A., Johnson, M. W. et al. · Kennedy Institute of Ethics Journal (2022)
Baker, P., Bright, S. J., Bruno, R. et al. · Journal of Psychopharmacology (2022)
Egan, G. F., Friston, K. J., Razi, A. et al. · Pharmacological Reviews (2022)
Cavanna, F., de la Fuente, L. A., Kuchar, M. et al. · Translational Psychiatry (2022)
van Elk, M., Yaden, D. B. · Neuroscience and Biobehavioral Reviews (2022)
Bonnelle, V., Cavarra, M., Feilding, A. et al. · British Journal of Pain (2022)
Carhart-Harris, R. L., Hipólito, I., Mago, J. et al. · Psyarxiv (2022)
Cavarra, M., Falzone, A., Kuypers, K. P. C. et al. · Frontiers in Psychology (2022)
Belser, A. B. · Frontiers in Psychology (2022)
Earp, D., Freidman-Wheeler, D., Graziosi, M. et al. · Frontiers in Psychology (2022)
Aday, J. S., Bradley, E. R., Heifets, B. D. et al. · Psychopharmacology (2022)
Blokland, A., Kloft, L., Ramaekers, J. G. et al. · European Neuropsychopharmacology (2022)
Gandy, S. · Journal of Psychedelic Studies (2022)
Dupuis, D., Timmermann, C., Watts, R. · Transcultural Psychiatry (2022)
Balaet, M. · Frontiers in Neuroscience (2022)
Family, N., Hendricks, P. S., Krediet, E. et al. · Journal of Psychopharmacology (2022)
Clarke, G., Gillan, C. M., Harkin, A. et al. · Frontiers in Psychiatry (2021)
Devenot, N., Pace, B. A. · Frontiers in Psychology (2021)
Rodríguez Arce, J. M., Winkelman, M. J. · Frontiers in Psychology (2021)
Corlett, P. R., Hutchinson, B., Leptourgos, P. et al. · Psyarxiv (2021)
Dupuis, D. · Transcultural Psychiatry (2021)
Akroyd, A., Evans, W. J., Muthukumaraswamy, S. et al. · International Journal of Environmental Research and Public Health (2021)
Dyck, E., Langlitz, N., Repantis, D. et al. · Frontiers in Psychiatry (2021)
Acquaviva, K. D., LeBaron, V. T., Mayer, C. E. · Journal of Psychoactive Drugs (2021)
Falchi, M., Feilding, A., Palhano-Fontes, F. et al. · Psychological Medicine (2021)
Avedisian, I., Eckert, A., Holze, F. et al. · Frontiers in Pharmacology (2021)
Carhart-Harris, R. L., Kettner, H., Letheby, C. et al. · Scientific Reports (2021)
Adams, C., Carhart-Harris, R. L., Douglass, H. et al. · Journal of Psychopharmacology (2021)
Kuiperes, Z., Schreiber, R. · Neurobiology of Learning and Memory (2021)
Carhart-Harris, R. L., Doblin, R., Ginsberg, N. et al. · Frontiers in Pharmacology (2021)
Baker-Jones, M., Blemings, A., Carhart-Harris, R. L. et al. · New England Journal of Medicine (2021)
Carhart-Harris, R. L., Kaertner, L. S., Kettner, H. et al. · Frontiers in Pharmacology (2021)
de Sousa Fernandes Perna, E. B., Fábregas, J. M., Kuypers, K. P. C. et al. · Psychopharmacology (2021)
Aday, J. S., Bloesch, E. K., Davis, A. K. et al. · ACS Pharmacology and Translational Science (2021)
Balaet, M., Buchborn, T., Carhart-Harris, R. L. et al. · Scientific Reports (2021)
Johnson, M. W., Nayak, S. · Pharmacopsychiatry (2020)
Nichols, D. E., Walter, H. · Pharmacopsychiatry (2020)
Brouwer, A., Carhart-Harris, R. L. · Journal of Psychopharmacology (2020)
Breeksema, J. J., Krediet, E., Niemeijer, A. R. et al. · CNS Drugs (2020)
Preller, K. H., Schilbach, L., Stämpfli, P. et al. · Scientific Reports (2020)
Feduccia, A. A., Garel, N., Greenway, K. T. et al. · Expert Review of Clinical Pharmacology (2020)
Chatziapostolou, M., de Haan, T., Freire, R. et al. · Association for Computing Machinery (2020)
Chi, T., Gold, J. A. · Journal of the Neurological Sciences (2020)
Aday, J. S., Bloesch, E. K., Davis, A. K. et al. · Neuroscience and Biobehavioral Reviews (2020)
Carhart-Harris, R. L., Family, N., Goble, D. J. et al. · Psychopharmacology (2019)
Preller, K. H., Vollenweider, F. X. · Frontiers in Psychiatry (2019)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Borgwardt, S., Duthaler, U., Holze, F. et al. · British Journal of Clinical Pharmacology (2019)
Carhart-Harris, R. L., Elliott, M. S., Maruyama, G. et al. · Psychology of Consciousness Theory Research and Practice (2019)
Ona, G., Troncoso, S. · Journal of Psychedelic Studies (2019)
Polito, V., Stevenson, R. J. · PLOS ONE (2019)
Carhart-Harris, R. L. · Current Opinion in Psychiatry (2019)
Garcia-Romeu, A., Richards, W. A. · International Review of Psychiatry (2018)
Carhart-Harris, R. L., Cassol, H., Erritzoe, D. et al. · Frontiers in Psychology (2018)
Hartogsohn, I. · Frontiers in Human Neuroscience (2018)
Swanson, L. R. · Frontiers in Pharmacology (2018)
Carhart-Harris, R. L., Moroz, M. · IEEE Explore (2018)
D’Souza, D. C., Schindler, E. A. D., Sloshower, J. A. et al. · Frontiers in Pharmacology (2018)
Nichols, D. E. · ACS Chemical Neuroscience (2018)
Grob, C. S., Nichols, D. E. · Forensic Science International (2018)
Carhart-Harris, R. L., Evans, J., Feilding, A. et al. · Psychopharmacology (2018)
Carhart-Harris, R. L., Erritzoe, D., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)
Atasoy, S., Carhart-Harris, R. L., Deco, G. et al. · Scientific Reports (2017)
Addy, P. H., Garcia-Romeu, A., Kersgaard, B. · Experimental and Clinical Psychopharmacology (2017)
Forstmann, M., Sagioglou, C. · Journal of Psychopharmacology (2017)
Liechti, M. E. · Neuropsychopharmacology (2017)
Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)
Borgwardt, S., Dolder, P. C., Harder, S. et al. · Translational Psychiatry (2017)
Kaelen, M. · Imperial College London (2017)
Dolder, P. C., Hammann, F., Kraemer, T. et al. · Clinical Pharmacokinetics (2017)
Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Hartogsohn, I. · Journal of Psychopharmacology (2016)
Dolder, P. C., Liechti, M. E., Schmid, Y. · Psychopharmacology (2016)
Bolstridge, M., Carhart-Harris, R. L., Feilding, A. et al. · Neuropsychologia (2016)
Bloomfield, M., Bolstridge, M., Carhart-Harris, R. L. et al. · Lancet Psychiatry (2016)
Borgwardt, S., Dolder, P. C., Liechti, M. E. et al. · Neuropsychopharmacology (2016)
Bolstridge, M., Carhart-Harris, R. L., Curran, H. V. et al. · PNAS (2016)
Nichols, D. E. · Pharmacological Reviews (2016)
Barnwal, P., Das, S., Mondal, S. et al. · Therapeutic Advances in Psychopharmacology (2016)
Carhart-Harris, R. L., Feilding, A., Kaelen, M. et al. · Journal of Psychopharmacology (2016)
Bolstridge, M., Carhart-Harris, R. L., Feilding, A. et al. · Psychological Medicine (2016)
McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)
Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Barrett, F. S., Bolstridge, M., Carhart-Harris, R. L. et al. · Psychopharmacology (2015)
Carhart-Harris, R. L., Feilding, A., Lebedev, A. V. et al. · Human Brain Mapping (2015)